1. Introduction {#sec0001}
===============

Perinatal infection with HIV (PHIV) affects the brain early in life. Selective or global cognitive deficits have been observed in infancy, childhood and/or adolescence, despite well-controlled disease, and have implications for mental health, well-being, and successful transitioning to adulthood ([@bib0015]; [@bib0026]; [@bib0027]; [@bib0033]). Previous neuroimaging studies of youth with PHIV have demonstrated differences in grey matter cortical and subcortical volume, white matter integrity, and global network connectivity in youth with PHIV compared to typically-developing youth ([@bib0002]; [@bib42]; [@bib0007]; [@bib0016]; [@bib0017]; [@bib0022], [@bib0023]; [@bib0024]; [@bib0031]; [@bib0037]). Youth with PHIV may be particularly vulnerable to structural brain damage given HIV infection during early, critical periods of brain development and prolonged exposure to the virus and chronic inflammation intermittently throughout development ([@bib0022]).

Normative patterns of structural brain development throughout the lifespan, particularly cortical grey matter, have previously been characterized by inverted-U curves. Past structural magnetic resonance imaging (MRI) have shown that cortical grey matter volumes increase and peak before puberty and then have shown a decrease in grey matter volume as synapses prune across adolescence into adulthood. Previous studies have differed on when this peak occurs (i.e., childhood vs. adolescence), with most findings showing widespread cortical thinning with increasing age during adolescence ([@bib0035]). Moreover, these normative patterns of development are heterogeneous by anatomic regions, grey matter metrics, individual subject characteristics, and different trajectories among disorders of neurodevelopment ([@bib0001]; [@bib0014]; [@bib0039]). To date, few neuroimaging studies have focused on how HIV alters brain structure at different ages ([@bib0018]). In adult males with HIV, brain structure trajectories exhibited more atrophy in the absence of, compared to those with continued, cART medication ([@bib0030]). However, how trajectories differ during key developmental time periods with HIV infection and with or without medication requires future investigation.

Various cortical grey matter components, such as surface area, cortical thickness, and gyrification, can be differentially affected in neurodevelopment of youth with PHIV. These grey matter metrics overlap in their changes over time, but also offer unique variance and are thought to relate to different biological factors ([@bib0034]) with different rates of maturation ([@bib0029]). Previous studies have examined the relationships between these measures of cortical morphometry and PHIV in pre-defined regions-of-interest of the brain ([@bib0028]). This study adds vertex-level analysis of grey matter anatomical differences of the brain, not limited to predefined regions of interest. The current study examined the relationships between specific morphometric measures of grey matter and PHIV, as well as the relationship between age and grey matter volume on the cortical surface in a cross-sectional sample of youth with PHIV. We hypothesized that youth with PHIV would have reduced grey matter measures (surface area, cortical thickness, and local gyrification) both globally and regionally compared to typically-developing youth.

2. Methods {#sec0002}
==========

2.1. Study population {#sec0003}
---------------------

We evaluated a cohort of 40 youth (age 11--20 years) with PHIV enrolled at a single site in 2007--2009 (the Ann and Robert H. Lurie Children\'s Hospital of Chicago) of the Adolescent Master Protocol (AMP) study, conducted by the Pediatric HIV/AIDS Cohort Study (PHACS) network (<https://phacsstudy.org/>), who underwent multi-modal MRI acquisition. In general, the PHACS AMP study is a longitudinal cohort study aimed at investigating long-term effects of HIV infection and antiretroviral therapy among youth with PHIV. This particular cohort of 40 youth with PHIV has previously been described ([@bib0016]; [@bib0022], [@bib0023]; [@bib0037]). Institutional review boards (IRB) at the participating site and the Harvard T. H. Chan School of Public Health approved the study. Parents, legal guardians, and youth with PHIV who were 18 years or older provided written informed consent for research participation; participating minor adolescents provided assent.

As a comparison group with harmonized MRI acquisition protocols, we selected a subset of 80 youth, presumed HIV-unexposed and uninfected, from the Pediatric, Imaging, Neurocognition, and Genetics (PING) study. The selection was made to 2:1 ratio of number of PING and PHACS participants, with group matching for age, race, ethnicity, caregiver education, and household income. For patients with missing data, multiple imputation was performed. Study population demographic, clinical, cognitive, and substance use data as well as imaging data were obtained through the PING portal after execution of data use requests and agreement to data use policies ([@bib0003]). We note that neuroimaging data in PING and PHACS were collected according to the same protocol.

2.2. Image acquisition and processing {#sec0004}
-------------------------------------

All MRIs of the brains were collected on 3.0 Tesla Siemens Magnetom Tim Trio Scanner as described in previous studies ([@bib0016]; [@bib0022], [@bib0023]; [@bib0037]). Structural MRIs were conducted using a T1-weighted, MP-RAGE sequence (sagittal, TR/TE/TI = 2,170/4.37/1,100 ms, FOV = 256 × 256 mm, flip angle = 7^o^, voxel resolution = 1 × 1 × 1.2 mm^3^, scan time = 8:08). No sedation was used for participants in either study. All selected subjects from the PING study and the PHACS study were scanned on 3T Siemens scanners using the same imaging protocol, except for 8 channel head coil used in the control youth and a 12 channel head coil in youth with PHIV. As in previous studies, PHACS structural MRI data were analyzed using the same processing pipeline as the PING participants ([@bib0016]; [@bib0022], [@bib0023]; [@bib0037]). Specifically, scans were analyzed using FreeSurfer 5.3.0 (processed on CentOS 6 × 86_64) to generate cortical surfaces (see <http://surfer.nmr.mgh.harvard.edu/>). The automated process involved motion correction, intensity normalization, Talairach transformation, segmentation of grey and white matter volumes, tessellation of boundaries, topology correction, and surface deformation to generate cortical surfaces. Inflated surfaces registered to spherical atlases allowed for analyses of surface morphometry, including cortical thickness, surface area, and local gyrification index ([@bib0006]; [@bib0008]; [@bib0011], [@bib0010]; [@bib43]; [@bib0032]). Quality assurance procedures were carried out according to FreeSurfer recommended protocols. SurfStat was used to perform exploratory vertex-wise analyzes on the surface (see <http://www.math.mcgill.ca/keith/surfstat/>) ([@bib0004]; [@bib0040]).

2.3. Statistical analyses {#sec0005}
-------------------------

Demographic characteristics of PHIV and control youth were summarized and compared using Fisher\'s exact tests for binary measures, Chi-Square tests for categorical variables, and Wilcoxon rank sum test for continuous measures. Spatial distribution vertex-wise analyses were performed to identify vertices (points on the cortical surface of the brain) and clusters (statistically significant spatially-contiguous regions) that were associated with morphometric differences between PHIV youth and control youth (from the PING sample). Mean cortical volume at each vertex over the whole brain was compared in youth with PHIV and control youth. Multivariate (multiple) linear regression was used to obtain clusters of significant (*p* \< 0.05) relationships between grey matter metrics on cortical surfaces (volume, surface area, cortical thickness, and local gyrification index) ([@bib0006]; [@bib0008]; [@bib0032]) and group (PHIV vs. control youth). Multiple comparisons were corrected with random field theory (RFT) ([@bib0004]); vertices that survived cluster-level correction using familywise error rate (FWER) \<0.05 were identified as significant on the surface using SurfStat ([@bib0040]). Models for each grey matter metric were used to test for group effect (PHIV vs. controls), adjusting for age at imaging (continuous) and sex. In this cross-sectional design, we evaluated the relationship of age with each grey matter metric (area, thickness, gyrification) by fitting a separate model within each of the groups (PHIV and control youth) for each metric as a function of age, adjusting for sex. For the analyses relating age to grey matter metric, two models were used. First, within-group analyses of grey matter metric (volume, cortical thickness, surface area, local gyrification) at each vertex was related to age, adjusting for sex. Second, as an exploratory analysis, scatter plots for both control youth and youth with PHIV were generated depicting age-grey matter volume relationships in regions identified significantly related to age in the control youth. Linear regression was performed. We fit a second model to explore a group by age interaction.

3. Results {#sec0006}
==========

3.1. Study population {#sec0007}
---------------------

Characteristics for the 40 youth with PHIV and 80 typically-developing youth are shown in [Table 1](#tbl0001){ref-type="table"}; as a result of group matching, distributions with respect to age, race, ethnicity, caregiver education, and household income were very similar. However, the female participants tended to be younger within the PHIV group than in the control youth (mean age (years) = 15.9 vs 17.1 years, respectively, *p* = 0.07) while the males tended to be older within the PHIV group than in control youth (mean age (years) = 17.6 vs 15.7 years, respectively, *p* = 0.005).Table 1Characteristics of study population by groupTable 1PHIV (*n* = 40)PING (*n* = 80)*p*-valueFemale (n(%))21 (53%)40 (50%)0.80Age (mean (SD))16.7 (2.4)16.3 (2.8)0.66Race (n(%))0.44 Black29 (73%)52 (65%) White10 (25%)28 (35%)Hispanic ethnicity (n(%))5 (13%)10 (13%)1.00Caretaker education (n(%))[a](#tb1fn2){ref-type="table-fn"}0.35 Less than high school7 (18%)8 (10%) High School or GED13 (33%)28 (35%) Some college or 2 year degree10 (25%)25 (31%) 4 year college3 (7.5%)12 (15%) Graduate School7 (18%)7 (8.8%)Annual household income (n(%))[b](#tb1fn3){ref-type="table-fn"}0.52 Less than 100002 (5%)5(6.3%) 10001--2000010 (25%)11 (14%) 20001--300006 (15%)14 (18%) 30001--400006 (15%)14 (18%) 40001--500003 (7.5%)3 (3.8%) 50001--10000011 (28%)21 (26%) greater than 1000002 (5%)12 (15%)HIV disease-severity measures (median (Q1, Q3) or N (%) for PHIV CD4% \< 15%17 (43%) Nadir CD4%16.5 (8.0,23.8) Age (years) at nadir CD4%5.7 (2.2,10.9) Nadir CD4 count236.0 (112.0, 392.5) Age (years) at nadir CD4 count8.2 (3.8, 11.6) Most recent[\*](#tb1fn1){ref-type="table-fn"} CD4 count627 (453.0, 846.0) Most recent[\*](#tb1fn1){ref-type="table-fn"} CD4%35.9 (27.6,42.9) Age (years) at most recent CD4%/CD4 count17.0 (14.9,18.2) Log peak HIV RNA viral load (copies/mL)5.7 (5.2,5.9) Age (years) at peak RNA2.5 (0.6,5.3) Most recent[\*](#tb1fn1){ref-type="table-fn"} RNA count \> 400 copies/mL6 (15) Age (years) at most recent RNA17.0 (14.9, 18.2) % of viral load \> 1000 copies/mL in past 5 years6.5 (0.0, 29.0) Age at start of cART3.5 (1.4 -6.3) ARV regimen at the time of scan  cART37(92%)  Not on cART1 (3%)  Not on any antiretrovirals2 (5%) CDC 'C' Classification9 (22%)[^1][^2][^3][^4][^5][^6]

3.2. Comparison of grey matter metrics between PHIV youth and control youth {#sec0008}
---------------------------------------------------------------------------

Mean cortical volume for each vertex across the whole brain was significantly different in youth with PHIV compared to control youth (youth with PHIV: 1.41, control youth 1.53, *t*(118) = −3.55, *p* \< 001). Compared to control youth, youth with PHIV exhibited cortical thinning that appeared limited in terms of both degree and range in anatomical locations overall: thinning appeared largely concentrated on the right hemisphere. Between-group analyses revealed that youth with PHIV had smaller cortical thickness than control youth in regions of the right and left primary motor areas, right superior frontal, left inferior parietal cortices, left posterior temporal, and right temporal lobes ([Fig. 1](#fig0001){ref-type="fig"}).Fig. 1Youth with PHIV(*n* = 40) had smaller cortical thickness than control youth (*n* = 80). Surface clusters (purple) indicate significantly smaller cortical thickness in PHIV than control youth with adjustment for age and sex (RFT-FWER, *p* \< 0.05). Cooler colors indicate youth with PHIV had smaller cortical thickness than controls. Warmer colors would be indicative of a thicker cortex in PHIV compared to controls, although no such findings were observed. Scale bar indicates range of standardized regression coefficients. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 1

In youth with PHIV, reduced surface area was found bilaterally, with most reductions in the lateral superior and temporal lobe bilaterally, as well as left medial temporal lobe and right cingulate cortex ([Fig. 2](#fig0002){ref-type="fig"}).Fig. 2Youth with PHIV (*n* = 40) had smaller surface area than control youth (*n* = 80). Surface clusters (purple) indicate significantly smaller surface area in PHIV than control youth with adjustment for age and sex (RFT-FWER, *p* \< 0.05). Cooler colors indicate youth with PHIV had smaller surface area than controls. Warmer colors would be indicative of a larger surface area in PHIV compared to controls, although no such findings were observed. Scale bar indicates range of standardized regression coefficients. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 2

Youth with PHIV exhibited significantly reduced local gyrification index, primarily in the left hemisphere. Specifically, youth with PHIV had lower gyrification than control youth in regions of the left lateral and medial frontal lobes, the left and right temporal lobes, and the right lateral parietal cortex and temporal lobe ([Fig. 3](#fig0003){ref-type="fig"}).Fig. 3Youth with PHIV (*n* = 40) had lower gyrification index than control youth (*n* = 80). Surface clusters (purple) indicate significantly lower gyrification index in PHIV than control youth with adjustment for age and sex (RFT-FWER, *p* \< 0.05). Cooler colors indicate youth with PHIV had lower gyrification index than control youth. Warmer colors would indicate youth with PHIV had larger gyrification index than controls, although no such findings were observed. Scale bar indicates range of standardized regression coefficients. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 3

3.3. Relationship between grey matter metrics correlation and age: within-group analyses {#sec0009}
----------------------------------------------------------------------------------------

In the control youth, distributed symmetric clusters in the left and right hemispheres, largely in the frontal cortex, showed negative association between age and grey matter volume. There were also additional clusters of negative associations between age and grey matter volume in the medial and lateral temporal lobe, though these clusters were smaller than those in the frontal lobe. In PHIV youth, there were no statistically significant relationships between age and grey matter volume ([Fig. 4](#fig0004){ref-type="fig"}). We did not observe any regions of the brain that had significant interaction between age and group, though the study may have been underpowered to detect such an effect. Similar results were found for cortical thickness, surface area, and local gyrification index (Supplemental Fig. 2). There were significant associations between age and grey matter metric (cortical thickness and gyrification) in distributed regions in bilateral frontal, parietal, and temporal lobe in the control youth, but not in youth with PHIV. For surface area, there were clusters in the left medial temporal lobe and right occipital lobe associated with age in the control youth, but not in youth with PHIV. Linear regression for age related to volume in regions identified significantly related to age in the control youth were performed. In youth with PHIV, there was no significant relationship (*r* = −0.1359, *p* = 4066.). In control youth, there was a significant relationship between age and volume (*r* = −0.5332, *p* \< 001.)Fig. 4Youth with PHIV (*n* = 40) did not show age-related volume reduction typically seen in control youth (*n* = 80). Clusters indicate significant relationship between age and volume within PHIV and control youth with adjustment for sex. Cooler colors indicate negative association between volume and age (RFT-FWER, *p* \< 0.05). Warmer colors would indicate there is a positive association between volume and age, though no such relationships were observed. Scales indicates ranges of coefficient of association for the magnitude of the volume-age relationships.Fig 4

4. Discussion {#sec0010}
=============

Using vertex-level analysis, we identified surface clusters of reduced grey matter thickness, surface area, and gyrification index in youth with PHIV compared to typically-developing youth in distributed regions throughout the cortex, including the frontal and parietal regions identified in previous studies of grey matter volume, but also in the temporal lobe of youth in the age range of 11--20 years old ([@bib42]; [@bib0023]). These findings occurred in the setting of mean cortical volume reduction over the whole brain in youth with PHIV compared to control youth. This confirms our hypothesis that multiple cortical grey matter morphometric measures (i.e., cortical thickness, surface area, and gyrification index) are vulnerable to HIV infection. This pattern is supported by earlier studies ([@bib42]), and the present study adds to earlier grey matter studies of this sample of youth with PHIV enrolled in the PHACS study ([@bib0022], [@bib0023]) . These findings of smaller grey matter volumes, reduced cortical surface area and decreased gyrification index have also been identified in a younger cohort 9--11-year old children with PHIV ([@bib0017]). Further, a recent study comparing volume, cortical thickness, and surface area between HIV- infected youth and HIV-exposed uninfected found subtle differences between the two groups, suggesting both *in utero* and postnatal effects of the virus ([@bib0007]). Interestingly, [@bib0007] identify reductions in surface area in the right temporal lobe as well as cortical thickness in the left frontal lobe, but not in other regions when comparing HIV-infected and HIV-exposed uninfected youth. These regions may be particularly vulnerable to HIV, while other regions found to be altered in the present study but not in [@bib0007] may relate more to timing of successful viral suppression, which differs between the studied populations.

A recently published systematic review highlighted that previous studies of structural magnetic resonance imaging have identified both similar and different grey matter regions affected across studies, which is also true in our findings ([@bib0018]). It is unclear why both different and similar regions or lateralization of findings have been identified in these neuroimaging studies. One potential explanation could be differential microglia concentration. In particular, animal studies have shown that in general, microglia have different concentrations in different regions of the brain ([@bib0021]; [@bib0036]). As microglia are a major reservoir of HIV in the central nervous system, one possibility is that this differential brain geographic concentration of microglia contributes to the observed grey matter differences observed in youth with HIV. Another potential reason that different regions have been identified from prior neuroimaging studies may be due to differences in comparison samples, for example comparing to typically-developing youth versus comparing to HIV-exposed uninfected, or comparing samples with slightly different age groups, geographic locations, or timing of viral suppression. Alternatively, other methodological differences such as in the analysis technique may be responsible for heterogenous findings.

Generally, reductions in surface area and gyrification in youth with PHIV were found in the frontal lobe, whereas the extent of frontal lobe differences in cortical thickness measures was much smaller. The pattern of changes in grey matter components identified in this study may reflect how PHIV most significantly affects neurodevelopment. Examining individual components such as cortical thickness (possibly reflecting changes in neuronal size, number of spines and synapses) and surface area (possibly reflecting cortical column generation) ([@bib0020]; [@bib0029]; [@bib0034]), is helpful to more fully understand specific deficits and neurological insults of PHIV across the duration of brain development. In addition, gyrification reflects radial expansion of cortex and can be especially sensitive to early defects of cortical development ([@bib0020]; [@bib0032]). The current understanding of gyrification is that cortical folds appear while *in utero* and gyrification increases through early childhood, stabilizes, then decreases in adolescence until early adulthood ([@bib0020]; [@bib0032]). The pattern of reductions in gyrification and surface area, but not thickness, may be partially explained by the observation that by the second year of life, cortical thickness has achieved 97% of adult values, compared with a total surface area of only 69% of expected young adult size ([@bib0025]), leading to continued surface area development throughout the first two decades of life. Thus, youth with PHIV may have more significant continued effects on cortical column generation and radial expansion of the cortex, and thus surface area and gyrification, respectively, in the frontal lobe beyond this period, rather than neuronal properties (cell size, arborization, spines) as reflected by lack of changes in cortical thickness.

Whether youth with PHIV have similar rates of decline or altered thinning in this age group compared to typically-developing youth is not yet known. Disorders of neurodevelopment, such as attention-deficit hyperactivity disorder, schizophrenia, and fetal alcohol syndrome have demonstrated distinct and varied trajectories of grey matter development ([@bib0001]; [@bib0014]). It is possible that, similarly to these neurodevelopmental disorders, greater benefits may be observed with earlier induction of interventions for individuals with PHIV in terms of determining trajectory of brain development ([@bib0014]; [@bib0041]). This cross-sectional study of the relationship of age with grey matter volume suggests that typically-developing youth demonstrate linear cortical volume reduction in this age range, thought to be a sign of effective maturation and pruning, whereas youth with PHIV may not undergo this maturation process in adolescence. This study may suggest that youth with PHIV have reduced grey matter cortical thickness and surface area to begin with, but do not undergo effective synaptic maturation. Other studies of blood markers of epigenetic aging suggest that youth with PHIV may have accelerated aging ([@bib0019]); however, how this correlates with grey matter morphometry is not yet understood.

The interpretations of these analyses must be understood in the context of their limitations. Given the limited sample size of the HIV-infected group, it is likely that we did not have sufficient power to detect group interactions on the association with age. Moreover, the non-linear inverted U shape relationship between cortical gray matter and age shown by previous larger studies spanned wider age ranges (for one study, the age range was 3--20 years ([@bib0003]), for another study, 4--22 years ([@bib0013])). For these studies, grey matter appeared to peak in later childhood, 10--12 years. The smaller, older age range of our study (11--20 years) may have prevented us from testing the non-linear hypothesis. In our study, analyses examining relationships between age and grey matter metrics made a simplifying assumption of linearity in age, which appeared to be satisfied within the typically-developing youth group. However, given the limited size of the HIV-infected group it is unclear whether we had too little power to detect associations with age, or whether the relationship with age was potentially non-linear and thereby obscured overall trends with age. Possible non-linear relationships may have also impacted our tests for interaction between age and HIV status. Larger future studies should study adolescents across a wide range of ages to more fully understand the complex relationships with age in this population.

Further, given our smaller sample size, it is not yet clear if HIV affects males and females differently. It should also be noted that sex is one of the strongest predictors of brain size, especially in the adolescent age range ([@bib0014]). Since males and females enter puberty at different ages, and synaptic pruning and the characteristic downward slope of the inverted-U grey matter occurs after the start of puberty ([@bib0012]; [@bib0014]), it is possible that males and females experience the interacting effects of HIV and brain volume changes differently.

Another limitation of our study is healthy volunteer bias. It is possible that the individuals who volunteer to participate in studies, including neuroimaging studies, may represent a healthier and wealthier sample of the general population ([@bib0045]; [@bib0046]). Socioeconomic status has been shown to affect brain volumes in prior structural magnetic resonance imaging studies ([@bib0047]; Lawson et al., 2013; [@bib0048], [@bib0049]). To minimize the effect of socioeconomic status, the present study matched the samples utilizing grouped ranges for two SES factors (annual household incomes and caregiver education). Despite these efforts, there were residual sociodemographic differences, with a higher frequency of participants with PHIV towards the lower end of the lowest income range compared to controls. Likewise, there were more control youth towards the high end of highest income range compared to youth with PHIV

Finally, this was a cross-sectional study of the relationship of age with cortical grey matter, providing a snapshot of possible longitudinal relationships. One study that examined subcortical abnormalities longitudinally observed shape differences in youth with PHIV at the initial evaluation, and the differences diminished over a year ([@bib0038]). This suggests that longitudinal differences may be minor when examining an endpoint; however, diminished changes at one year could also reflect an altered neurodevelopmental trajectory. Future studies should evaluate the correlations of these structural abnormalities with cognitive and behavioral outcomes. In order to further characterize the neurodevelopmental trajectories of youth with PHIV, larger longitudinal neuroimaging studies with multiple timepoints across the lifespan are warranted.
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[^1]: GED = General Education Development test passed.

[^2]: Cart = combination antiretrovial therapy (regimen including at least 3 drugs from at least 2 drug classes).

[^3]: CDC = Centers for Disease Control.

[^4]: Most recent = closest clinical data to neuroimaging scan.

[^5]: One missing value of PING subjects imputed.

[^6]: Eleven missing values of PING subjects imputed.
